| Protein Name | Protein Kinase C beta |
| Gene | PRKCB |
| UniProt ID | P05771 |
| PDB IDs | 1DG6, 2I0E, 3PFQ |
| Molecular Weight | 76.7 kDa |
| Subcellular Localization | Cytoplasm, plasma membrane, nucleus |
| Protein Family | Protein Kinase C family (classical PKC) |
Protein Kinase C beta is a Protein Kinase C family (classical PKC) member. The protein contains the characteristic domain structure including [domain descriptions]. The molecular weight is approximately 76.7 kDa, and the protein localizes to Cytoplasm, plasma membrane, nucleus.
Protein kinase C beta (PKCβ) exists as two isoforms: PKCβI and PKCβII, generated by alternative splicing. Both require DAG and calcium for activation. PKCβ is involved in B-cell receptor signaling, angiogenesis, and metabolic regulation. In the brain, PKCβ plays roles in synaptic plasticity, memory formation, and blood-brain barrier (BBB) function. PKCβ modulates neurotransmitter release and neuronal excitability. It is also expressed in endothelial cells where it regulates vascular permeability.
PKCβ contributes to diabetic complications, cancer angiogenesis, and metastasis. In Alzheimer's disease, PKCβ is involved in amyloid-β toxicity and tau pathology. PKCβ is a therapeutic target and PKCβ inhibitors have been developed for diabetic retinopathy and cancer.
This protein is a potential therapeutic target for neurodegenerative diseases. Research is ongoing to develop small molecule inhibitors and biologics that modulate its activity.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.